PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | – | 0 | – | 0.00% | – |
Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q1 2020 | $99,000 | +3200.0% | 35 | -73.5% | 0.00% | -100.0% |
Q4 2019 | $3,000 | – | 132 | -10.2% | 0.00% | – |
Q3 2019 | $0 | – | 147 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 147 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $1,000 | 0.0% | 147 | -31.0% | 0.00% | 0.0% |
Q3 2018 | $1,000 | 0.0% | 213 | -4.9% | 0.00% | 0.0% |
Q2 2018 | $1,000 | 0.0% | 224 | -2.2% | 0.00% | 0.0% |
Q1 2018 | $1,000 | – | 229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |